Int Neurourol J.
2011 Dec;15(4):184-191.
Antiproliferative Factor Signaling and Interstitial Cystitis/Painful Bladder Syndrome
- Affiliations
-
- 1Division of Cancer Biology and Therapeutics, Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Jayoung.Kim@cshs.org
- 2The Urological Diseases Research Center, Children's Hospital Boston, Boston, MA, USA.
- 3Departments of Surgery and Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Abstract
- A unique glycopeptide, antiproliferative factor (APF), has been suggested as a urinary biomarker and potential mediator of long-term bladder disorder Interstitial Cystitis/Painful Bladder Syndrome. There is no known cause for this disease. Several mechanistic approaches have been employed to address the underlying mechanism whereby APF regulates cellular responses in the bladder epithelium. A summary of recent literature is provided, and is focused on signal transduction pathways and networks that are responsive to APF.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Potential Use of Antiproliferative Factor as a Targeting Therapy in Painful Bladder Syndrome/Interstitial Cystitis
- Diagnosis and Management of Interstitial Cystitis/ Painful Bladder Syndrome
- Interstitial Cystitis/Painful Bladder Syndrome: Prevalence Estimates, Quality of Life and Depression among Older Adult Korean Women
- Diagnosis and treatment of interstitial cystitis and painful bladder syndrome
- Update on the Pathology and Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: A Review
